The suspension of the Federal government's R&D Start program, purportedly for being too successful, flew in the face of Australia's need to compete in the global biotechnology arena, Prof Adrienne Clarke has warned. [ + ]

A study is underway in NSW and WA to examine endangered ecosystems using genetic techniques. [ + ]

The Ian Clunies Ross Memorial Foundation has called for nominations for its 2003 National Science and Technology Award. [ + ]

Drug development company BioDiem has appointed a pharmaceutical industry heavyweight to its board in the lead-up to a public listing this year. [ + ]

Some of the most-used global databases of DNA and amino acid sequences are riddled with errors and there is no quick fix in sight. [ + ]

Perth-based research pharma Chemeq (ASX: CMQ) has begun work on its $25 million production facility at Rockingham, in the city's south. [ + ]

Australia has no plans to sign an international protocol covering the environmental impact of trade in living genetically modified organisms (LMOs), with trade officials calling for more discussion on how it would affect grain trade. [ + ]

Investors have lost patience with companies failing to deliver on expectations, analysts said today (Monday, May 6), with ResMed the latest stock hit by their wrath. [ + ]

The ANU's new Dean of the Faculty of Science believes the outlook for Australian science is positive - with a resurgence of support on the horizon.

Australia's National Medical Cyclotron (NMC) - the electrical machine that has given doctors the power to accurately diagnose thousands of Australians - is celebrating ten years of operation.

Prana Biotechnology's theory for treating Alzheimer's disease with zinc-targeted drugs has won support from a paper published this week in the Proceedings of the National Academy of Science. [ + ]

Sirtex Medical has entered into an agreement with German-based AEA Technology, a supplier of radioactive products, to assist in distributing its SIR-Spheres internationally. [ + ]

The biological sciences are now the driving force for the development of advanced computing, according to Compaq Computer Corp executive Lionel Binns. But there's a catch, he warned - there aren't enough computer scientists to go around, and this would increasingly be a problem for the industry. [ + ]

UK-based analyst Datamonitor has tipped a massive increase in the global gene chip market over the next four years, from $322 million in 2000 to $1.2 billion by 2006. [ + ]

Sleep disorder specialist ResMed's shares took a beating on the Australian Stock Exchange this morning (May 3), dropping more than 22 per cent when the company suggested that it would not be able to meet its fourth quarter earnings estimate. [ + ]